Yaron Werber
Stock Analyst at TD Cowen
(2.35)
# 2,283
Out of 5,124 analysts
45
Total ratings
46.88%
Success rate
1.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Initiates: Buy | n/a | $33.87 | - | 1 | Dec 18, 2025 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $13.08 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $23.00 | +226.09% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $43.83 | +16.36% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $840.95 | +36.27% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $79.11 | +25.14% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $1.56 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.61 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $303.81 | +9.94% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $27.27 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $41.21 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $27.90 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $213.24 | -28.25% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $95.20 | +28.15% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $27.15 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $21.74 | +208.19% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.74 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.83 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.58 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $27.16 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.68 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $8.78 | +7,018.45% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.00 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $30.80 | +23.38% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.70 | - | 1 | Oct 26, 2021 |
RAPT Therapeutics
Dec 18, 2025
Initiates: Buy
Price Target: n/a
Current: $33.87
Upside: -
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $13.08
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $23.00
Upside: +226.09%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $43.83
Upside: +16.36%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $840.95
Upside: +36.27%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $79.11
Upside: +25.14%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.56
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.61
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $303.81
Upside: +9.94%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $27.27
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $41.21
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $27.90
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $213.24
Upside: -28.25%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $95.20
Upside: +28.15%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $27.15
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $21.74
Upside: +208.19%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $31.74
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.83
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.58
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $27.16
Upside: -
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.68
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $8.78
Upside: +7,018.45%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $11.00
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $30.80
Upside: +23.38%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $21.70
Upside: -